Dynavax Technologies Corp (NASDAQ:DVAX)
A biopharmaceutical company that discovers and develops Toll-like Receptor 9 and agonist-based products to treat and prevent infectious diseases, allergies, cancer and chronic inflammatory.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Stong findings for a much-needed vaccine; results exceed early prognosis. Large populations with Rag Weed Allergy get sustained releif.
Recs
Bear Stearns upgraded to outperform 11/17
Recs
alot of good things in their pipeline
Recs
Heavy insider trading.
Recs
This small cap stock has just broken out with experimantal studies showing their new product does effectively relieve ragweed allergies.
Recs
New product hype will die down in a few weeks.
Recs
MY on3 D4y PrED1c+10n on +Hi5 5+OcK 1$ +7%;-)
Recs
I think that this company is a great 'take-over' candidate.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 21 - 28 of 28 : « Previous 1 2